Infectious Disease Microtissue Models
Infectious Disease (e.g., SARS-CoV-2)
Research-Use OnlyActive
Key Facts
Indication
Infectious Disease (e.g., SARS-CoV-2)
Phase
Research-Use Only
Status
Active
Company
About Aurita Bioscience
Aurita Bioscience is a private biotechnology company developing a disruptive 3D cell culture ecosystem designed to overcome the limitations of traditional 2D and hydrogel-based 3D models. Its core technologies—LLS® microgels and Darcy™ perfusion plates—create a tunable, physiologically relevant microenvironment that supports complex cellular interactions, prolonged viability, and high-fidelity in situ imaging. The company is actively engaged in collaborative research projects in oncology, infectious disease (including SARS-CoV-2), and immunotherapy (CAR-T), positioning itself as a critical enabler for more predictive drug discovery and development.
View full company profile